US FDA to revise contact lens guidance in effort to reduce eye infections
This article was originally published in SRA
The US Food and Drug Administration is planning to update some of its contact lens and lens solution testing and labeling standards in an effort among other things to prevent potential eye infections related to the products. The FDA will seek input on its plans from its ophthalmic device advisory panel on 13 May1,2.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The European public assessment report for Novartis's advanced breast cancer therapy, Piqray (alpelisib), includes some interesting insights into what EU regulators are looking for in drug company clinical trials.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.